Evaluation of the pilot program on the real-time drug utilization review system in South Korea
Physician/pharmacist Co-DUR detected more adverse events than pharmacist-only DUR. Between-prescriptions review showed more alerts than within-prescription review. Doctors readily reflected clinical information of patients in the DUR process. Pharmacists double-checked when doctors do not voluntarily modify pop-up alerts.
drug utilization review inappropriate prescribing real-time system expenditures